Hrt Financial LP Lantheus Holdings, Inc. Transaction History

Hrt Financial LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$60.27 - $90.75 $278,507 - $419,355	-4,621 Reduced 24.33%	14,371 $998,000
Q2 2023 Aug 11, 2023	BUY	$82.41 - $99.65 $1.57 Million - $1.89 Million	18,992 New	18,992 $1.59 Million
Q4 2022 Feb 10, 2023	BUY	$48.76 - $77.67 $4 Million - $6.38 Million	82,135 New	82,135 $4.19 Million
Q1 2022 May 16, 2022	SELL	$24.28 - $56.64 $442,940 - $1.03 Million	-18,243 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$22.54 - $30.44 $271,043 - $366,041	-12,025 Reduced 39.73%	18,243 $527,000
Q3 2021 Nov 15, 2021	BUY	$24.23 - $28.59 $733,393 - $865,362	30,268 New	30,268 $777,000
Q1 2021 May 17, 2021	SELL	$13.77 - $21.66 $412,934 - $649,540	-29,988 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$10.75 - $14.91 $322,371 - $447,121	29,988 New	29,988 $404,000

534

68.9M

679K

414K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.16B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.